SIGA Technologies Inc - Asset Resilience Ratio
SIGA Technologies Inc (SIGA) has an Asset Resilience Ratio of 2.85% as of September 2018. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See SIGA Technologies Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2009–2017)
This chart shows how SIGA Technologies Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see total assets of SIGA Technologies Inc.
Liquid Assets Composition Over Time
This chart breaks down SIGA Technologies Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read SIGA Technologies Inc (SIGA) total liabilities for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $4.09 Million | 2.85% |
| Total Liquid Assets | $4.09 Million | 2.85% |
Asset Resilience Insights
- Limited Liquidity: SIGA Technologies Inc maintains only 2.85% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
SIGA Technologies Inc Industry Peers by Asset Resilience Ratio
Compare SIGA Technologies Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Beijing Tongrentang Co Ltd
SHG:600085 |
Drug Manufacturers - Specialty & Generic | 0.50% |
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Neuland Laboratories Limited
NSE:NEULANDLAB |
Drug Manufacturers - Specialty & Generic | 9.65% |
|
China Resources Double-Crane Pharmaceutical Co Ltd
SHG:600062 |
Drug Manufacturers - Specialty & Generic | 1.18% |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267 |
Drug Manufacturers - Specialty & Generic | 0.01% |
Annual Asset Resilience Ratio for SIGA Technologies Inc (2009–2017)
The table below shows the annual Asset Resilience Ratio data for SIGA Technologies Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2017-12-31 | 7.40% | $10.70 Million | $144.67 Million | +1.10pp |
| 2016-12-31 | 6.30% | $10.14 Million | $160.98 Million | -- |
| 2015-12-31 | 0.00% | $0.00 | $185.73 Million | -- |
| 2014-12-31 | 2.40% | $4.00 Million | $166.39 Million | -- |
| 2013-12-31 | 0.00% | $0.00 | $193.82 Million | -- |
| 2012-12-31 | 0.00% | $0.00 | $105.84 Million | -- |
| 2011-12-31 | 0.00% | $0.00 | $90.38 Million | -- |
| 2010-12-31 | 55.49% | $15.00 Million | $27.03 Million | +36.20pp |
| 2009-12-31 | 19.29% | $5.00 Million | $25.92 Million | -- |
About SIGA Technologies Inc
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.